# OnCo record paper-llovet-tace-lancet-2002 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-llovet-tace-lancet-2002/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-llovet-tace-lancet-2002" ;
  schema:name "Arterial embolisation or chemoembolisation versus symptomatic treatment in unresectable hepatocellular carcinoma"@en ;
  schema:description "This Barcelona trial was the first to show that transarterial chemoembolisation lengthens survival in intermediate-stage liver cancer, with two-year survival of 63 percent against 27 percent with supportive care, making it the standard for this stage."@en ;
  schema:url <https://onco.cc/key-papers/paper-llovet-tace-lancet-2002/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:citation <https://doi.org/10.1016/S0140-6736(02)08649-X>, <https://pubmed.ncbi.nlm.nih.gov/12049862/> ;
  schema:sameAs <https://doi.org/10.1016/S0140-6736(02)08649-X> ;
  schema:datePublished "2002"^^xsd:gYear ;
  schema:author "Llovet JM, Real MI, Montaña X, et al." ;
  onco:cancers <https://onco.cc/cancers/hcc-intermediate/> ;
  onco:journals <https://onco.cc/journals/lancet/> .